Healthcare provider profile · identity verified

Scott L Vonderfecht, M.D.

Family Practice · MILLIGAN, NE · NPI 1023099678

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	543	71
Atorvastatin Calcium	Atorvastatin Calcium	370	75
Metoprolol Succinate	Metoprolol Succinate	367	58
Omeprazole	Omeprazole	348	55
Amlodipine Besylate	Amlodipine Besylate	296	64
Losartan Potassium	Losartan Potassium	263	54
Potassium Chloride	Potassium Chloride	253	35
Lisinopril	Lisinopril	217	47
Pantoprazole Sodium	Pantoprazole Sodium	212	29
Gabapentin	Gabapentin	201	39
Furosemide	Furosemide	192	36
Metformin Hcl	Metformin Hcl	192	42
Alprazolam	Alprazolam	183	24
Meloxicam	Meloxicam	167	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	156	30
Rosuvastatin Calcium	Rosuvastatin Calcium	156	33
Eliquis	Apixaban	138	19
Sertraline Hcl	Sertraline Hcl	132	18
Pravastatin Sodium	Pravastatin Sodium	125	22
Allopurinol	Allopurinol	120	23
Tamsulosin Hcl	Tamsulosin Hcl	119	22
Duloxetine Hcl	Duloxetine Hcl	116	11
Carvedilol	Carvedilol	110	22
Mirtazapine	Mirtazapine	100	13
Simvastatin	Simvastatin	99	23
Sucralfate	Sucralfate	98	suppressed
Donepezil Hcl	Donepezil Hcl	95	suppressed
Jardiance	Empagliflozin	93	17
Trazodone Hcl	Trazodone Hcl	90	18
Prednisone	Prednisone	88	68
Montelukast Sodium	Montelukast Sodium	87	16
Myrbetriq	Mirabegron	81	suppressed
Nebivolol Hcl	Nebivolol Hcl	81	12
Alendronate Sodium	Alendronate Sodium	74	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	72	15
Hydrochlorothiazide	Hydrochlorothiazide	72	17
Glipizide	Glipizide	70	12
Venlafaxine Hcl Er	Venlafaxine Hcl	67	suppressed
Spironolactone	Spironolactone	65	13
Farxiga	Dapagliflozin Propanediol	64	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	63	48
Albuterol Sulfate Hfa	Albuterol Sulfate	62	27
Azithromycin	Azithromycin	62	53
Escitalopram Oxalate	Escitalopram Oxalate	58	suppressed
Atenolol	Atenolol	57	12
Clopidogrel	Clopidogrel Bisulfate	54	suppressed
Ozempic	Semaglutide	54	suppressed
Tramadol Hcl	Tramadol Hcl	54	suppressed
Glipizide Er	Glipizide	53	11
Bisoprolol Fumarate	Bisoprolol Fumarate	50	11
Paroxetine Hcl	Paroxetine Hcl	50	suppressed
Warfarin Sodium	Warfarin Sodium	50	suppressed
Clonazepam	Clonazepam	49	suppressed
Ezetimibe	Ezetimibe	48	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	46	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	suppressed
Pregabalin	Pregabalin	43	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	41	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	39	22
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	14
Xarelto	Rivaroxaban	33	suppressed
Famotidine	Famotidine	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Mupirocin	Mupirocin	28	20
Torsemide	Torsemide	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	26	suppressed
Levofloxacin	Levofloxacin	26	23
Buspirone Hcl	Buspirone Hcl	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	19
Lorazepam	Lorazepam	23	suppressed
Celecoxib	Celecoxib	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Fluconazole	Fluconazole	21	13
Memantine Hcl Er	Memantine Hcl	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Primidone	Primidone	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Cephalexin	Cephalexin	20	14
Gemtesa	Vibegron	20	suppressed
Ranolazine Er	Ranolazine	20	suppressed
Dutasteride	Dutasteride	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	16
Divalproex Sodium Er	Divalproex Sodium	18	suppressed
Haloperidol	Haloperidol	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Ramipril	Ramipril	16	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Fentanyl	Fentanyl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Valsartan	Valsartan	15	suppressed
Cefdinir	Cefdinir	14	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Letrozole	Letrozole	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Risperidone	Risperidone	13	suppressed
Selegiline Hcl	Selegiline Hcl	13	suppressed
Tobramycin	Tobramycin	13	12
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Armodafinil	Armodafinil	12	suppressed
Buprenorphine	Buprenorphine	12	suppressed
Cozaar	Losartan Potassium	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Enbrel	Etanercept	12	suppressed
Finasteride	Finasteride	12	suppressed
Kerendia	Finerenone	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error